Accessibility Statement

This website contains a tool about estimating the risk of recurrence in neoadjuvant-treated breast cancer patients.

Technical information about the accessibility of this website

The University of Turku seeks to ensure the accessibility of its website in compliance with the Web Accessibility Directive of the European Parliament. In Finland, the Web Accessibility Directive is implemented by the act on offering digital services. This accessibility statement is related to the bcnatreccalc.utu.fi website.

Compliance status

In its entirety, the accessibility of the bcnatreccalc.utu.fi website complies with the requirements of the Web Content Accessibility Guidelines (WCAG) 2.1 (level AAA).

Drafting this accessibility statement

This accessibility statement has been drafted on 17 May 2024. The basis for the statement is the accessibility evaluation carried out by the Research IT of the University of Turku. The accessibility has been tested by using keyboard navigation and a NVDA screen reader. The testing has been carried out with the help of Mozilla Firefox Developer Tools’ accessibility tools, the aXe browser extension and the Webaim site. The testing concluded that this website is accessible with keyboard navigation and a screen reader.

Feedback and contact information

If you do not think that the website complies with the statutory accessibility requirements, please give us feedback first at softdev@utu.fi. We will get back to you within 14 working days.

If you are not satisfied with the answer or do not get an answer at all within the specified time limit, you can contact the Regional State Administrative Agency for Southern Finland.

For more information, please see https://www.webaccessibility.fi/.

We constantly seek to improve the accessibility at the University of Turku! Accessibility at the University of Turku